5-oxo-6-8-11-14-eicosatetraenoic-acid has been researched along with Irritable-Bowel-Syndrome* in 1 studies
1 other study(ies) available for 5-oxo-6-8-11-14-eicosatetraenoic-acid and Irritable-Bowel-Syndrome
Article | Year |
---|---|
5-oxoETE triggers nociception in constipation-predominant irritable bowel syndrome through MAS-related G protein-coupled receptor D.
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder that is characterized by chronic abdominal pain concurrent with altered bowel habit. Polyunsaturated fatty acid (PUFA) metabolites are increased in abundance in IBS and are implicated in the alteration of sensation to mechanical stimuli, which is defined as visceral hypersensitivity. We sought to quantify PUFA metabolites in patients with IBS and evaluate their role in pain. Quantification of PUFA metabolites by mass spectrometry in colonic biopsies showed an increased abundance of 5-oxoeicosatetraenoic acid (5-oxoETE) only in biopsies taken from patients with IBS with predominant constipation (IBS-C). Local administration of 5-oxoETE to mice induced somatic and visceral hypersensitivity to mechanical stimuli without causing tissue inflammation. We found that 5-oxoETE directly acted on both human and mouse sensory neurons as shown by lumbar splanchnic nerve recordings and Ca Topics: Animals; Arachidonic Acids; Calcium; Case-Control Studies; Colon; Constipation; Ganglia, Spinal; Humans; Irritable Bowel Syndrome; Male; Mice; Mice, Inbred C57BL; Nociception; Receptors, G-Protein-Coupled; Sensory Receptor Cells; Signal Transduction | 2018 |